Stock RKLB ROCKET LAB USA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Rocket Lab USA, Inc.

Equities

RKLB

US7731221062

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-10 pm EDT 		5-day change 1st Jan Change
4.11 USD -3.52% Intraday chart for Rocket Lab USA, Inc. +2.75% -25.68%
May. 07 Rocket Lab USA Q1 Loss Narrows, Revenue Rises MT
May. 06 Transcript : Rocket Lab USA, Inc., Q1 2024 Earnings Call, May 06, 2024

Summary

  • Overall, the company has poor fundamentals for a medium to long-term investment strategy.
  • From a short-term investment perspective, the company presents a deteriorated fundamental configuration.

Strengths

  • According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • The opinion of analysts covering the stock has improved over the past four months.
  • Over the past twelve months, analysts' opinions have been strongly revised upwards.
  • The group usually releases upbeat results with huge surprise rates.

Weaknesses

  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • The company has insufficient levels of profitability.
  • The company is in debt and has limited leeway for investment
  • The company's "enterprise value to sales" ratio is among the highest in the world.
  • The company appears highly valued given the size of its balance sheet.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
  • Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
  • The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.

Ratings chart - Surperformance

Sector: Aerospace & Defense

1st Jan change Capi. Investor Rating ESG Refinitiv
ROCKET LAB USA, INC. Stock Rocket Lab USA, Inc.
-25.68% 2.03B -
RTX CORPORATION Stock RTX Corporation
+26.36% 141B
C
GENERAL DYNAMICS CORPORATION Stock General Dynamics Corporation
+14.16% 81.2B
B
NORTHROP GRUMMAN CORPORATION Stock Northrop Grumman Corporation
+1.42% 70.27B
A-
BAE SYSTEMS PLC Stock BAE Systems plc
+25.53% 52.53B
B
ROLLS-ROYCE HOLDINGS PLC Stock Rolls-Royce Holdings plc
+41.34% 44.34B
A-
L3HARRIS TECHNOLOGIES, INC. Stock L3Harris Technologies, Inc.
+4.26% 41.65B
B+
HINDUSTAN AERONAUTICS LIMITED Stock Hindustan Aeronautics Limited
+34.52% 31.01B
C-
RHEINMETALL AG Stock Rheinmetall AG
+86.69% 25.05B
B
AXON ENTERPRISE, INC. Stock Axon Enterprise, Inc.
+17.46% 22.9B
C-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. RKLB Stock
  4. Ratings Rocket Lab USA, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW